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Abstract
Background: Clostridium botulinum C2 toxin and Clostridium perfringens iota toxin are binary exotoxins, which ADP-
ribosylate actin in the cytosol of mammalian cells and thereby destroy the cytoskeleton. C2 and iota toxin consists of two
individual proteins, an enzymatic active (A-) component and a separate receptor binding and translocation (B-) component.
The latter forms a complex with the A-component on the surface of target cells and after receptor-mediated endocytosis, it
mediates the translocation of the A-component from acidified endosomal vesicles into the cytosol. To this end, the B-
components form heptameric pores in endosomal membranes, which serve as translocation channels for the A-
components.
Methodology/Principal Findings: Here we demonstrate that a 7-fold symmetrical positively charged ß-cyclodextrin
derivative, per-6-S-(3-aminomethyl)benzylthio-ß-cyclodextrin, protects cultured cells from intoxication with C2 and iota
toxins in a concentration-dependent manner starting at low micromolar concentrations. We discovered that the compound
inhibited the pH-dependent membrane translocation of the A-components of both toxins in intact cells. Consistently, the
compound strongly blocked transmembrane channels formed by the B-components of C2 and iota toxin in planar lipid
bilayers in vitro. With C2 toxin, we consecutively ruled out all other possible inhibitory mechanisms showing that the
compound did not interfere with the binding of the toxin to the cells or with the enzyme activity of the A-component.
Conclusions/Significance: The described ß-cyclodextrin derivative was previously identified as one of the most potent
inhibitors of the binary lethal toxin of Bacillus anthracis both in vitro and in vivo, implying that it might represent a broad-
spectrum inhibitor of binary pore-forming exotoxins from pathogenic bacteria.
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Introduction
Various pathogenic bacteria produce binary exotoxins, which
are composed of two non-linked proteins, an enzyme (A-) com-
ponent and a separate binding and translocation (B-) component.
The B-component binds to a receptor on the surface of mam-
malian target cells, forms a complex with the A-component, and
mediates the transport of the A-component into the cytosol, where
the enzymatic active A-component modifies its substrate. The
binary toxins include lethal toxin and edema toxin from Bacillus
anthracis, the causative agents of anthrax disease and the family of
binary actin-ADP-ribosylating toxins mainly produced by clos-
tridia (for review see [1]). The binary actin-ADP-ribosylating
toxins are potent enterotoxins associated with severe human and
animal intestinal diseases [2–7] and include C2 toxin from C.
botulinum (types C and D) [3], iota toxin from C. perfringens [7,8],
CDT toxin from C. difficile [9–11] and CST toxin from C. spiroforme
[12]. The A-components of these toxins mono-ADP-ribosylate G-
actin at arginine-177 which turns G-actin into a capping molecule
and prevents further polymerization of actin filaments [8,13,14].
As a consequence, the actin filaments depolymerise and this results
in a complete destruction of the actin cytoskeleton and a rounding
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up of toxin-treated cells [2,3,6,15–18]. Finally, intoxicated cells
undergo caspase-dependent cell death [19,20].
The C. botulinum C2 toxin is the prototype of this toxin family (for
review see [21]). It consists of the A-component C2I (,49 kDa)
[22,23] and the B-component C2II (,80 or 100 kDa, depending on
the strain [24,25]. Following proteolytic activation, C2II forms ring-
shaped heptamers (C2IIa) that bind to asparagine-linked carbohy-
drate structures, which are present on the surface of all the
mammalian cell types tested so far [24,26–29]. C2I binds either to
receptor-bound C2IIa or to soluble C2IIa prior to receptor-binding
[30]. Cell-bound C2IIa/C2I complexes are internalized by
receptor-mediated endocytosis [31,32] and reach the early
endosomal vesicles. There, C2I translocates as an unfolded protein
across the endosomal membranes into the cytosol and this step is
mediated by C2IIa and facilitated by host cell chaperones [24,33–
35]. More importantly, the acidification of the endosomal lumen
triggers the conversion of C2IIa heptamers into their pore con-
formation and the insertion of C2IIa pores in endosomal mem-
branes and therefore, pore formation by C2IIa is absolutely essential
for translocation of C2I into the cytosol [24,36–39]. In planar lipid
bilayer membranes, C2IIa forms ion-permeable, cation-selective
and voltage-gated heptameric channels [36]. The C2IIa pores insert
into membranes in an oriented manner and are blocked by the
addition of C2I to the cis-side of the membrane [38–39]. It was
suggested that C2I interacts with negatively charged residues
localized in the pore vestibule [39].
The cellular uptake of the related C. perfringens iota toxin, which
consists of the A-component Ia and the channel-forming B-
component Ib follows a widely comparable mechanism [40] with
distinct differences described below (see Discussion). Like C2IIa,
activated Ib forms heptameric transmembrane pores in vitro [41]
and in cell membranes [40], which mediate translocation of Ia into
the cytosol.
Novel pharmacological inhibitors of the translocation pores of
binary toxins represent attractive candidates to prevent the
transport of the A-components into the cytosol and thereby
protect cells from intoxication. It was reported earlier that specially
designed ß-cyclodextrin derivatives carrying 7-positively charged
groups (7+ß-CD) blocked the translocation pore formed by the B-
component of anthrax toxins, which is Protective Antigen (PA63)
[42–45]. One compound, per-6-S-(3-aminomethyl)benzylthio-ß-
cyclodextrin (AMBnTßCD), efficiently blocked the PA63 pores in
subnanomolar concentrations on the single molecule level in vitro
(compound 14b in ref. [43]) and protected cultured macrophage-
like cells from intoxication with anthrax lethal toxin (PA+LF),
IC50 = 0.560.2 mM [43]. Most importantly, the compound
completely protected Fischer F344 rats [46] from intoxication
with lethal toxin and in combination with the antibiotic cipro-
floxacin significantly increased the survival of mice in an infection
model of anthrax [46], clearly demonstrating its value as a
potential drug against anthrax. Several structurally related 7+ß-
CDs also protected rabbit erythrocytes against the pore-forming
cytotoxic agent of Staphylococcus aureus, a-hemolysin [44,47] and
irreversibly blocked heptameric a-hemolysin pores in planar lipid
membranes [44]. Here, we demonstrate that AMBnTßCD
efficiently protects cultured epithelial cells from intoxication with
C2 and iota toxins and blocks the ion current through heptameric
channels formed by C2IIa and Ib in planar lipid membranes in
vitro. This compound was previously identified as one of the most
powerful 7+ß-CD inhibitors of anthrax toxins. It is now selected as
the most potent blocker of the C2IIa channel by the screening of
several 7+ß-CDs with the planar lipid membrane technique. The
inhibitory effects of AMBnTßCD were investigated in vitro and in
intact cells to discover the underlying molecular mechanism. We
show that the compound efficiently inhibits the membrane
translocation of C2I and Ia into the cytosol of intact cultured cells.
Results
The ß-cyclodextrin derivative AMBnTßCD protects
mammalian cells from intoxication with the C2 toxin of C.
botulinum
To test whether AMBnTßCD has an effect on the intoxication
of cells in the presence of C2 toxin, we pre-treated cultured Vero
epithelial cells for 30 min with 5, 10 or 20 mM final concentrations
of this compound in complete medium and subsequently added
the two toxin components C2IIa (200 ng/ml) and C2I (100 ng/
ml) to the medium. Cells were further incubated at 37uC and the
toxin effect was analyzed in terms of cell rounding, a specific and
well-established endpoint to monitor the mode of action of the
actin-ADP-ribosylating toxin in the cytosol of mammalian cells. As
shown in Fig. 1A, 100% of the cells were round after 4 h of toxin-
treatment in the absence of AMBnTßCD while there was no
toxin-induced cell rounding in the presence of 10 or 20 mM of
AMBnTßCD. In contrast, 5 mM of AMBnTßCD only showed a
slight protective effect after a 4 h of incubation with C2 toxin. As
expected by the observed changes in cell morphology, the actin
was completely ADP-ribosylated in lysates from cells treated with
C2 toxin alone while significantly less actin was ADP-ribosylated
in the cytosol of cells treated with C2 toxin in the presence of
AMBnTßCD (data not shown). To analyze the inhibitory effect of
AMBnTßCD on the intoxication of Vero cells with C2 toxin in
more detail, we performed a time course and counted the number
of total cells and round cells from the pictures to calculate the
percentage of round cells for each sample (Fig. 1B). AMBnTßCD
inhibited the intoxication of cells with C2 toxin in a time- and
concentration-dependent manner and even after a 24 h incuba-
tion period there was still a significant (approx. 50%) inhibitory
effect in the case of 10 and 20 mM AMBnTßCD (Fig. 1B).
The described inhibitory effect of AMBnTßCD was not restricted
to a certain cell-type because we observed a very efficient inhibition
of C2 intoxication of CHO-K1 fibroblasts by 10 mM of AMBn
TßCD even after 24 h (Fig. 1C). Also, we excluded that the solvent
DMSO had any effect on the intoxication of Vero or CHO-K1 cells
by C2 toxin (data not shown). Moreover, the treatment of the cells
with 10 or 20 mM of AMBnTßCD alone did not change the
morphology of Vero cells (Fig. 1A) or CHO-K1 cells, even when the
compound was applied to cells for 72 h (data not shown). Therefore,
such concentrations of AMBnTßCD were used in the further
experiments of this study.
Interestingly, the AMBnTßCD but not the structurally related
neutral methyl-ß-cyclodextrin (MßCD) inhibited the intoxication
of Vero cells with C2 toxin when 10 mM of each ß-cyclodextrin
were applied to cells (Fig. 2). In addition, it was reported that
much higher (5–10 mM) concentrations of MßCD decreased the
binding of the B-components of C2 and iota toxins to the cell
surface by removing cholesterol from the cell membrane [31,48]
and protects cells from intoxication with C2 toxin [31]. However,
the finding that low micromolar concentrations of MßCD did not
affect intoxication with C2 toxin implies that the molecular
mechanism underlying the protective effect of AMBnTßCD is
specific for this particular compound and not for ß-cyclodextrin
molecules per se and therefore we investigated this mechanism in
more detail. Note that a nonmodified (uncharged) ß-cyclodextrin
did not inhibit the cytotoxic effect of Bacillus anthracis lethal toxin
on the mouse macrophage-like RAW 264.7 cells up to a 100 mM
concentrations [42].
Tailored ß-Cyclodextrin Blocks Toxin Translocation
PLoS ONE | www.plosone.org 2 August 2011 | Volume 6 | Issue 8 | e23927
Tailored ß-Cyclodextrin Blocks Toxin Translocation
PLoS ONE | www.plosone.org 3 August 2011 | Volume 6 | Issue 8 | e23927
AMBnTßCD inhibited the intoxication of Vero cells with C2
toxin not only when it was administered to the cells prior to the
toxin but also when AMBnTßCD and C2 toxin were applied at
the same time point or when AMBnTßCD was added 5 min after
C2 toxin application (Fig. 3). In contrast, most cells rounded up
after 3 h of toxin-treatment when AMBnTßCD was applied
15 min or more after the toxin. It has been shown, that most of the
membrane-bound C2 toxin is internalized by receptor-mediated
endocytosis by epithelial cells within 15 min and no more toxin is
detectable on the cell surface after 30 min [31]. Therefore, this
result is a strong indication that AMBnTßCD interferes with the
C2IIa-mediated uptake of C2I into the cytosol of target cells and
not with the C2I-catalyzed ADP-ribosylation of actin that occurs
when C2I is already delivered into the host cell cytosol. To verify
this hypothesis, we tested whether AMBnTßCD has an effect on
the enzyme activity of C2I in vitro by performing ADP-ribosylation
of actin from Vero lysate by C2I in the absence and presence of
AMBnTßCD. The data shown in Fig. 4 clearly demonstrate that
10 mM of AMBnTßCD had no effect on the ADP-ribosyltransfer-
ase activity of C2I.
AMBnTßCD inhibits the pH-dependent membrane
translocation of C2I through C2IIa pores
Having excluded that AMBnTßCD acts on the enzyme activity
of C2 toxin, we focused on the molecular mechanism by which
AMBnTßCD inhibits the uptake of C2 toxin into the cytosol of the
target cells. First, we tested whether AMBnTßCD inhibited the
binding of C2 toxin to its receptor on the cell surface. Vero cells
were incubated for 30 min at 4uC with C2 toxin to allow the toxin
to bind to the receptor. Subsequently, cells were washed to remove
unbound C2 toxin and incubated for 3 h at 37uC in toxin-free
medium containing 10 mM of AMBnTßCD. For a control, cells
were incubated with medium alone. As shown in Fig. 5A, C2
toxin-treated cells were round but the toxin-mediated cell-
rounding was inhibited in the presence of AMBnTßCD, strongly
suggesting that AMBnTßCD had no effect on the binding of C2
toxin to the cell surface receptor. Consistently, a comparable
amount of cell-associated C2I protein was detectable in the lysates
from those cells using Western blot analysis with an anti-C2I
Figure 1. Pre-treatment of Vero epithelial cells and CHO-K1 fibroblasts with the ß-cyclodextrin derivative AMBnTßCD protects cells
from intoxication with C. botulinum C2 toxin. A. Time- and concentration-dependent inhibition of the intoxication of Vero cells by C2 toxin. Vero
cells were grown in 24-well dishes to subconfluency and treated with 5, 10 and 20 mM final concentrations of AMBnTßCD for 30 min at 37uC.
Subsequently C2 toxin (200 ng/ml C2IIa+100 ng/ml C2I) was added and cells were further incubated with the toxin in the presence of AMBnTßCD at
37uC. For a control, cells were left untreated or treated with C2 toxin alone or with AMBnTßCD alone. Pictures were taken after 2, 4, 6 and 24 h. The
morphology of cells is shown after 4 h of C2 toxin-treatment (scale bar = 100 mm) (A). B. The number of total cells and round cells were counted from
the pictures and the percentages of round cells calculated (lower panel). Values are given as mean 6 S.D. (n = 3) and significance was tested for each
time point between toxin-treated samples with or without AMBnTßCD by using the student’s t-test (***p,0.0005; ***,0.005; *,0.05). C. AMBnTßCD
inhibits the intoxication of CHO-K1 cells with C2 toxin. CHO-K1 cells were incubated with 10 mM of AMBnTßCD and after 30 min C2 toxin was applied
exactly as described above. For a control, cells were treated without toxin or without AMBnTßCD or were left untreated. Pictures from the cells were
taken after 3, 6 and 24 h (scale bar = 25 mm) and the percentages of round cells were determined. Values are given as mean 6 S.D. (n = 3) and
significance was tested for each time point between toxin-treated samples with or without AMBnTßCD by using the student’s t-test (***p,0.0005).
doi:10.1371/journal.pone.0023927.g001
Figure 2. The ß-cyclodextrin derivative AMBnTßCD but not
methyl-ß-cyclodextrin protects Vero cells from intoxication
with C2 toxin when administered at 10 mM final concentration.
Vero cells grown in 24-well plates were treated for 1 h at 37uC with
either AMBnTßCD (10 mM) or methyl-ß-cyclodextrin (MßCD, 10 mM) and
subsequently cells were challenged with C2 toxin (200 ng/ml
C2IIa+100 ng/ml C2I). After 1.5 and 2.5 h of incubation at 37uC, pictures
were taken to determine the percentages of round cells. Values are
given as mean 6 S.D. (n = 3) and significance was tested for each time
point between toxin-treated samples and samples treated with either
AMBnTßCD plus C2 toxin or MßCD plus C2 toxin by using the student’s
t-test (***p,0.0005; n. s. = not significant).
doi:10.1371/journal.pone.0023927.g002
Figure 3. The time point of AMBnTßCD application determines
the protective effect of this compound against intoxication of
Vero cells with C2 toxin. Vero cells were grown in 24-well plates and
AMBnTßCD (10 mM) was applied to the cell medium either 30, 15 or
5 min before C2 toxin (200 ng/ml C2IIa+100 ng/ml C2I) was added to
the cells or AMBnTßCD was added together with the toxin into the
medium. In parallel, AMBnTßCD was added to the cells 5, 15, 30 or
60 min after the toxin. For a control, cells were treated with medium
alone or with C2 toxin in the absence of AMBnTßCD. The cells were
incubated for 3 h at 37uC and pictures were taken to determine the
percentages of round cells. Values are given as mean 6 S.D. (n = 3) and
significance was tested for each sample treated with C2 toxin and
AMBnTßCD against cells treated with C2 toxin only using the student’s
t-test (***p,0.0005; **p,0.005; *p,0.05; n. s. = not significant).
doi:10.1371/journal.pone.0023927.g003
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antibody (Fig. 5B), clearly indicating that AMBnTßCD did not
interfere with receptor-binding of C2 toxin. Importantly, equal
amounts of cell lysates were analyzed as confirmed by Ponceau S-
staining of the blotted proteins (not shown). Moreover, the
detected C2I protein specifically bound to cells via the C2IIa
component. We have confirmed earlier that in the absence of
C2IIa only a negligible amount of C2I was detectable by Western
blot analysis [35].
Therefore, AMBnTßCD most likely inhibits a later step of toxin
uptake and thus we next focused on its effect on the pH-dependent
translocation of C2I through the lumen of C2IIa pores across cell
membranes into the cytosol. We performed a well-established
translocation assay, which mimics the endosomal conditions on
the surface of intact cells. This assay allows for the monitoring of
the direct translocation of C2I through C2IIa pores, which are
formed in the plasma membrane under acidic conditions. First, we
incubated Vero cells for 30 min at 4uC with C2IIa plus C2I to
enable toxin binding to the cells. Then, we exposed the cells for
5 min to warm acidic medium (pH 4.5, 37uC) [49] to trigger
membrane insertion and pore-formation by C2IIa and the
membrane translocation of C2I through the pores into the cytosol.
To test whether AMBnTßCD inhibits membrane translocation of
C2I under such conditions, the acidic shift was performed in the
absence and the presence of AMBnTßCD. The cells were further
incubated at 37uC in neutral medium to allow the ADP-
ribosylation of actin by the translocated C2I in the cytosol and
after 30 and 90 min of incubation the toxin-induced cell rounding
was detected. Also, all the steps of this assay were performed in the
presence of Baf A1 to inhibit the physiological uptake of C2 toxin
via acidified endosomal vesicles. As shown in Fig. 6, most of the
C2 toxin-treated cells were round when they were exposed to the
acidic medium in the absence of AMBnTßCD. However, there
was no cell rounding when the toxin-treated cells were not exposed
to an acidic shift. Moreover, the acidic conditions alone did not
cause cell rounding (not shown). Most important, the presence of
AMBnTßCD during the acidification step completely prevented
C2 toxin-induced cell rounding, even after 90 min, clearly
demonstrating that the compound blocked the C2IIa-mediated
translocation of C2I across cell membranes.
AMBnTßCD protects Vero cells from intoxication with
iota toxin from C. perfringens
Prompted by the results obtained for C2 toxin, we finally
investigated whether AMBnTßCD blocks the translocation pores of
the binary iota toxin, likewise. We found that AMBnTßCD
inhibited the intoxication of Vero cells with iota toxin. Cells were
pre-treated for 30 min with various concentrations of AMBnTßCD
before iota toxin was added to the medium. The presence of
AMBnTßCD protected cells from intoxication with iota toxin in a
time- and concentration-dependent manner as shown in Fig. 7A.
Concentrations of 10 and 20 mM of AMBnTßCD had a partial but
significant protective effect for up to 24 h. As we have observed
before for C2 toxin, AMBnTßCD exhibited its full protective effect
when it was applied before, simultaneously or even shortly after the
toxin, but there was much less protection when AMBnTßCD was
applied 15 or 30 min after iota toxin (Fig. 7B), implying that
AMBnTßCD had no inhibitory effect after the enzyme component
of the toxin reached the cytosol. Consistent with our results obtained
for C2 toxin, AMBnTßCD inhibited the pH-induced membrane
translocation of iota toxin (Fig. 7C), implying that this cyclodextrin
derivative interferes with the same molecular mechanisms during
cellular uptake of the binary C2 and iota toxins. Moreover, iota
toxin represents the prototype of the group of closely related iota-
like toxins and therefore, these findings strongly suggest that
AMBnTßCD might be a universal inhibitor for the complete family
of binary actin ADP-ribosylating toxins from pathogenic clostridia.
AMBnTßCD blocks C2IIa and Ib Channels in Planar Lipid
Bilayers
AMBnTßCD and structurally related positively charged ßCDs
were recently reported to electrostatically interact with the
negative charges inside the lumen of the PA63 channel of anthrax
[42,43,45] directly blocking the translocation pathway of the pore.
To find out if the mechanism of AMBnTßCD-induced inhibition
of the channel-forming components of clostridial binary toxins is
identical to that of Bacillus anthracis toxins, we first reconstituted
C2IIa and Ib pores into planar lipid bilayers and studied the effects
of AMBnTßCD on the multichannel membranes in 0.1 M KCl
(Fig. 8). We found a profound inhibition of both C2IIa (Fig. 8, top)
and Ib (Fig. 8, bottom) ion current at nM – low mM concentrations
of the blocker (Fig. 8B).
To study the kinetics of channel-blocker interactions on a single-
molecule/single-channel level, we switched to 1 M KCl concen-
trations. Higher salt concentrations produce a higher signal to
noise ratio in single-channel measurements. Moreover, the
statistically reliable quantitative analysis of single-channel blockage
turned out to be difficult at physiological salt concentrations
because the residence time of AMBnTßCD in the channel was
very long (minutes). The typical recordings of the ion channel
through a single C2IIA and a single Ib pore in 1 M KCl are shown
in Fig. 9A (left and right respectively). Single-channel conduc-
tances of (150610) pS and (9065) pS (50 mV) for C2IIa and Ib
are in excellent agreement with the results of the pioneering
studies performed by Roland Benz’s group [36,41]. We never
observed the two types of single-channel insertions for C2IIa and
Ib oligomers in contrast to PA63 where two types of insertions with
slightly different conductance and current noise characteristics
were routinely detected [45,50]. Interestingly, the two types of
non-Markov channel gatings previously reported [51–55] and
recently studied on a single-channel level [45] for the PA63
Figure 4. AMBnTßCD does not inhibit the ADP-ribosylation of
actin by C2I in vitro. Vero lysate (30 mg of protein in 25 ml) was
incubated for 10 min at 37uC with 50 ng of C2I and 10 mM biotin-
labelled NAD+ in the presence or absence of 20 mM P5115. The proteins
were separated by SDS-PAGE, blotted onto nitrocellulose and the ADP-
ribosylated (i.e. biotin-labelled) actin was detected with streptavidin-
peroxidase and a subsequent chemiluminescence reaction. The
intensity of bands was determined by densitometry using the Adobe
Photoshop 7.0 software.
doi:10.1371/journal.pone.0023927.g004
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channel were also observed with C2IIa and Ib single channels.
The first type of PA63-like gating is promoted by applied
transmembrane voltage [36,39,41] and resembles the voltage-
induced closure observed in many known b-barrel channel-
forming proteins reconstituted into lipid bilayers ([56] and see
related discussion in [39]). Like PA63, both C2IIa and Ib possess
voltage-independent fast-flickering between the open and com-
pletely closed states with the current noise power spectra
containing a 1/f-like component (data not shown). This finding
agrees with the multichannel experiments [57] where 1/f noise for
the C2IIa channels has also been reported; similar switches
between the open and closed states of the Ib individual pores were
also mentioned before [41]. The current flickering corresponding
to 1/f noise was filtered here by averaging over a time interval of
100 ms. The longest 1/f events can still be seen in the absence of
AMBnTßCD (Fig. 9A, top current tracks).
In the presence of AMBnTßCD on the cis side of the chamber,
both channels get spontaneously blocked with the frequency of
blockages depending on AMBnTßCD concentration (Fig. 9A,
three lower tracks). Within the accuracy of our measurements,
these blockages are complete. As with the PA63 pore, current
fluctuations induced by AMBnTßCD at 1 M KCl can be
described as a two-state Markov process, one state being an open
pore and a second state being a pore occupied by one blocker
molecule. This is manifested by single-exponential distributions
both of the duration of AMBnTßCD blockages, Toff and the
channel lifetime in the unblocked state (the time between
successful blockages), Ton (Fig. 9B).
Discussion
Here we have performed a series of in vitro and cell-based
experiments to demonstrate that the low molecular weight com-
pound AMBnTßCD, a positively charged tailor-made ß-cyclo-
dextrin derivative, is an efficient pharmacological inhibitor for the
clostridial C2 and iota toxins. We showed that the compound
docks to the transmembrane pores formed by the B-components
C2IIa and Ib in planar lipid bilayer membranes and thereby
blocks the ion-permeable channels in vitro. Consistent with this
observation, we found that AMBnTßCD inhibits the pH-
dependent translocation of the A-components C2I and Ia through
the translocation pores C2IIa and Ib, respectively, across the
Figure 5. Effect of AMBnTßCD on receptor binding of C2 toxin. Vero cells were incubated for 30 min at 4uC with C2 toxin (200 ng/ml
C2IIa+100 ng/ml C2I) to enable toxin binding to the receptor on the cell surface. Then, the medium was removed and cells were washed to remove
any unbound toxin. Fresh medium containing 10 mM of AMBnTßCD was added and cells were further incubated at 37uC to trigger internalization of
the cell-bound C2 toxin. As a control, cells were incubated with fresh medium without AMBnTßCD or left untreated. After 3 h, pictures were taken to
determine the percentages of round cells (scale bar = 100 mm) (A). Values are given as mean 6 S.D. (n = 3) and significance was tested between toxin-
treated samples with or without AMBnTßCD by using the student’s t-test (***p,0.0005). B. Western blot detection of cell-associated C2I protein.
Equal amounts of cell lysate proteins were subjected to SDS-PAGE, blotted and C2I was visualized in a Western blot with a specific antibody against
the N-terminal domain of C2I. Purified C2I protein was run as a control in the same gel (not shown).
doi:10.1371/journal.pone.0023927.g005
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cytoplasmic membranes of intact cultured epithelial cells. Thus,
the data strongly suggests that AMBnTßCD blocks the transloca-
tion pores of the toxins in endosomal membranes thereby
preventing translocation of the A-components from the endosomal
lumen into the cytosol of target cells. Because AMBnTßCD did
not interfere with the earlier steps of toxin uptake or the toxin-
catalyzed ADP-ribosylation of actin, the data imply that the
blocking of the translocation pores is the molecular mechanism
underlying the observed protective effects of this compound. Note
that fluorescent microscopy data [58] indicate that bCD might
also bind to the PA63 precursor – the receptor-bound heptameric
prepore - before endocytosis takes place. We cannot completely
exclude that similar binding occurs between AMBnTßCD and
C2IIa and Ib prepores.
Cellular uptake of the binary C2 and iota toxins as
compared with Bacillus anthracis toxins
Although C2 toxin and iota toxin belong to the same family of
binary actin-ADP-ribosylating toxins and share a widely compa-
rable cellular uptake mechanism, there are some remarkable
differences between both toxins [29,41,48,59]. Iota toxin repre-
sents the prototype of the iota-like toxins, which include CDT
toxin from C. difficile, and CST toxin from C. spiroforme (for review
see ref 1). The B-components of these toxins form biologically
active toxin complexes with the A-component of any other
member of this group but not with C2 toxin. C2IIa binds to a
carbohydrate receptor [27], which is ubiquitously present on
mammalian cells and therefore, all cell types tested so far are
sensitive towards C2 toxin. In contrast, Ib binds to an as yet
unidentified protein receptor [60] and some mammalian cell lines
are relatively resistant towards iota toxin. Also, the A-component
of C2 toxin translocates from early endosomes into the cytosol,
while the A-component of iota toxin most likely escapes from
acidified vesicles between early and late endosomes [59] and in
contrast to C2 toxin, iota toxin requires a membrane potential
gradient in addition to a pH-gradient across the endosomal
membrane [59].
As with binary clostridial toxins, the channel-forming B-
component (PA63) of Bacillus anthracis toxins mediates the trans-
location of the A-components from endosomal vesicles into the
cytosol (for details see ref. [61,62]). The enzyme components are
lethal factor (LF, 90 kDa), a metalloprotease that cleaves MAP
kinase kinases and induces the cell death of macrophages [63–65]
and edema factor (EF, 89 kDa), which is an adenylyl cyclase
[66,67]. At mildly acidic conditions, C2IIa, Ib and PA63 form ion-
permeable and cation-selective oligomeric channels in planar lipid
membranes [36,37,41,50–55,57,68] with a single tunnel inside.
PA63 strongly prefers cations over anions with a permeability ratio
of 20:1 [51]. 10:1 and 6:1 cation to anion ratios were also reported
for C2IIa and Ib channels, respectively [36,41]. C2IIa and Ib are
most likely heptamers and PA63 was reported to form octamers as
well as heptamers [50,69,70]. The ability of small molecules
carrying one or two positive charges to block an ion current
through the PA63, C2IIa, and Ib channels was shown earlier
[37,41,52–54,71,72]. One of the compounds, positively charged
chloroquine not only inhibited C2IIa pores in vitro (Kd = 10 mM in
0.15 M KCl) [72], but also prevented translocation of C2I across
the cell membrane when studied with intact cultured cells [37]. At
the same time, only a weak interaction was reported for
chloroquine (Kd = 0.22 mM in 0.1 M KCl) with Ib channels and
chloroquine did not efficiently protect cells from intoxication with
iota toxin [41].
AMBnTßCD effectively inhibits C2, iota, and anthrax
toxins
Recently Karginov et al. exploited the well-known information
of the molecular structure of PA63 prepores for the structure-based
design of tailored ß-cyclodextrin derivatives [42,43] with
AMBnTßCD being one of the most active compounds against
anthrax lethal toxin [43,46]. Here we discovered an even broader
applicability of AMBnTßCD. It inhibits the pH-dependent
membrane translocation of the A-components of clostridial C2
and iota toxins by blocking the transmembrane channels formed
by the B-components of these toxins. The question arises: is the
mechanism of AMBnTßCD-induced blockage exactly the same
for all three pores?
In 0.1 M KCl concentrations, AMBnTßCD blocks ion current
through multichannel membranes with affinity decreasing in
order IC50(PA63) = 0.1 nM, IC50(C2IIa) = 1.5 nM, and IC50(Ib) =
23 nM ([43] and Fig. 8B). These numbers are influenced by a
recently described 2nd mode of 7+ß-CD-induced action – blocker-
enhanced voltage gating that is much more pronounced at lower
salt concentrations [45]. This effect was also observed with C2IIa
and Ib channels (data not shown). Note that the less voltage-
sensitive Ib pore is only weakly affected by this 2nd mode of
AMBnTßCD action. Since the physiological importance of voltage
gating is questionable, it is important to compare the binding
constants for the 1st, equilibrium mode of AMBnTßCD action.
This is only possible in single-channel measurements at 1 M KCl
where long-lasting voltage gating events can be excluded. The
Figure 6. AMBnTßCD inhibits the pH-dependent membrane
translocation of C2 toxin across cytoplasmic membranes of
intact cells. Vero cells were incubated for 30 min at 37uC with 100 nM
Baf A1 and subsequently for 30 min at 4uC in serum-free medium with
C2 toxin (400 ng/mL C2IIa+200 ng/ml C2I) or without toxin for control.
Then, the medium was removed and cells were exposed to a short
acidic shift with warm medium (5 min, pH 4.5, 37uC, Baf A1) to trigger
pore formation by C2IIa and membrane translocation of C2I. In parallel,
cells were exposed for 5 min to neutral medium (37uC, pH 7.5, Baf A1)
as a control. In some samples, AMBnTßCD (10 mM) was present during
acidic shift. Subsequently, the medium was changed and cells were
further incubated at 37uC in neutral medium, still in the presence of Baf
A1 to prevent the normal uptake of C2 toxin via acidified endosomes.
Pictures were taken after 30 and 90 min of incubation. The percentages
of round (i.e. intoxicated) cells were determined from the pictures,
values are given as mean 6 S.D. (n = 3). Significance was tested for each
time point between samples, treated with C2 under acidic conditions in
the absence or presence of AMBnTßCD by using the student’s t-test
(***p,0.0005).
doi:10.1371/journal.pone.0023927.g006
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average residence times of the AMBnTßCD compound in the
pores, Toff(C2IIa) = (1.160.28) s and Toff(Ib) = (0.9660.19) s,
(Fig. 9B) are very close to the time reported earlier (1.1560.2) s
for the blocking of the PA63 channel by AMBnTßCD under
identical conditions (1 M KCl, 250 mV) [43]. This is a very
interesting observation taking into account that structurally related
7+ß-CDs often demonstrate quite distinct binding off-rates in case
ofPA63 channels [43]. Similar behavior is found for C2IIa
channels (data not shown). For instance with PA63, a 200 times
difference in Toff values was reported earlier for different 7+ß-CDs
[43,44]. Moreover, the on-rate constants kon = 1/(topencbl), where
cbl is the bulk AMBnTßCD concentration, equal to (2.360.5)610
7
(Ms)21 (C2IIa) and (1.860.3)6107 (Ms)21 (Ib) which is compara-
ble with the on-rate constants reported for PA63-7+b-CD
interactions, kon = (2.360.6)610
7 (Ms)21 [45]. The similarity
between the kon values, that are mostly determined by the radius
of the channel entrance, may be attributed to the structural
resemblance between these heptameric pores (at least at the
endosomal cap sides). The dissociation constants KD = koff/kon in
1 M KCl solutions are also close KD(C2IIa) = 4610
28 M, and
KD(Ib) = 5.6610
28 M. This similarity strongly suggests close
mechanisms of AMBnTßCD-induced pore blockage implying
that similar sets of negatively charged amino-acid residues are
involved in the interaction with the blocker.
In recent detailed study [45] it was shown that structurally
related per-6-(3-aminopropylthio)-b-cyclodextrin (AmPrßCD)
blocks PA63 pores without translocating through. The binding
site for AmPrßCD was estimated to be approximately at 15% from
the channel cis-entrance suggesting interaction between seven
positive charges on the blocker and seven negative charges in the
channel cap [42,45]. On the other hand, about one order of
magnitude increase in 7+ß-CD binding affinity was achieved as a
result of introducing aromatic (Bn) groups into the alkyl spacers of
the 7+ß-CD derivatives, [43,46]. The specific hydrophobic
interactions inside PA63 (especially for aromatic compounds) were
attributed to the existence of the Q-clamp formed by a ring of
seven solvent-exposed aromatic phenylalanine groups, Phe-427
[71]. It is tempting to suggest that the hydrophobic interaction of
the aromatic groups of AMBnTßCD with the Q-clamps contrib-
utes significantly to the overall blocker-pore interactions. Note that
the Phe at the corresponding position is conserved in both C2IIa
and Ib [72], but the importance of the Q-clamp for the iota toxin
transport is not clear so far. It is not obvious, however, if
AMBnTßCD, which has a diameter of about 27 Å, can slip deep
enough into the channel to be able to interact with the Q-clamp
Figure 7. AMBnTßCD protects Vero cells from intoxication with
iota toxin from C. perfringens and inhibits the pH-dependent
membrane translocation of the toxin. A. Time- and concentration-
dependent inhibition of the intoxication of Vero cells with iota toxin.
Vero cells grown in 24-well dishes to subconfluency were treated for
30 min at 37uC with 2, 5, 10 and 20 mM final concentrations of
AMBnTßCD or without AMBnTßCD for control. Iota toxin (200 ng/ml
Ib+100 ng/ml Ia) was added and cells were further incubated at 37uC
with the toxin in the absence or presence of AMBnTßCD. Pictures were
taken after the indicated incubation periods, the number of total cells
and round cells were counted and the percentages of round cells
calculated. Values are given as mean 6 S.D. (n = 3) and significance was
tested for each time point between iota toxin-treated samples without
and with the respective concentration of AMBnTßCD by using the
student’s t-test (***p,0.0005; ***,0.005; *,0.05). B. The time point of
AMBnTßCD application determines the protective effect against iota
toxin. AMBnTßCD (10 mM) was applied to Vero cells at 30, 15 or 5 min
before iota toxin (200 ng/ml Ib+100 ng/ml Ia), together with iota toxin
or 5, 15 or 30 min after the toxin. As a control, cells were treated with
medium or with iota toxin alone. The cells were incubated for 3 h at
37uC and pictures were taken to determine the percentages of round
cells. Values are given as mean 6 S.D. (n = 3) and significance was
tested between cells treated with iota toxin alone and cells treated with
toxin and AMBnTßCD by using the student’s t-test (***p,0.0005;
**p,0.005). C. AMBnTßCD inhibits the pH-dependent membrane
translocation of iota toxin across the cytoplasmic membranes of intact
Vero cells. Cells were incubated for 30 min at 37uC with 100 nM Baf A1
and subsequently for 30 min at 4uC in serum-free medium with iota
toxin (1000 ng/mL Ib+500 ng/ml Ia) or without toxin for control. Then,
10 mM of AMBnTßCD were added (for control no AMBnTßCD) and the
pH of the medium was adjusted to 4.5 with HCl (for control pH 7.5) and
cells were exposed for 15 min to 37uC to trigger pore formation by Ib
membrane translocation of Ia. Subsequently, cells were further
incubated at 37uC in neutral medium containing Baf A1 and pictures
were taken after 45 min and 3 h of incubation. The percentages of
round (i. e. intoxicated) cells were determined, values are given as mean
6 S.D. (n = 3). Significance was tested for each time point between
samples treated with iota toxin under acidic condition in the absence or
presence of AMBnTßCD by using the student’s t-test (***p,0.0005).
doi:10.1371/journal.pone.0023927.g007
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located at 40% of the channel length. More detailed single-
channel studies of channel-blocker interaction are currently under
way. Recent developments in 7+ß-CDs chemistry and synthesis
[73], and nanopore applications [74] provide growing possibilities
for these studies.
Taken all together, AMBnTßCD effectively blocks the translo-
cation of the A-components by blocking the pores formed by B-
components both in vitro and in cell assays for at least three binary
pore-forming toxins: Clostridial C2 and iota as well as Bacillus
anthracis toxins. The protective effect of AMBnTßCD against
anthrax lethal toxin in mice was already demonstrated [42] and
next steps will include animal studies to test whether AMBnTßCD
prevents the adverse effects caused by C2 and iota toxins in vivo.
Most pertinent, a protective effect of this compound towards the
toxin-induced diarrhea could be investigated in the mouse intestinal
loop assay [4]. In conclusion, the compound AMBnTßCD might
serve as a universal pharmacological inhibitor against binary pore-
forming toxins produced by pathogenic bacteria and, therefore,
represents a highly attractive potential drug candidate.
Materials and Methods
Materials and Reagents
Cell culture medium DMEM and fetal calf serum were obtained
from Invitrogen (Karlsruhe, Germany) and HAM’s F12 from
GIBCO (Karlsruhe, Germany). Cell culture materials were
obtained from TPP (Trasadingen, Switzerland). The recombinant
C2 toxin components C2I and C2IIa were prepared and activated
as described earlier [23,24]. The components Ia and Ib from the
iota toxin were prepared as described earlier [75]. The following
chemical reagents were used: KCl, MES, KOH, and HCl (Sigma-
Aldrich, USA); ‘‘purum’’ hexadecane (Fluka, Buchs, Switzerland);
diphytanoyl phosphatidylcholine (Avanti Polar lipids, Inc., Ala-
baster, AL); pentane (Burdick and Jackson, Muskegon, MI),
agarose (Bethesda Research Laboratory, Gaithersburg, MD).
Doubly distilled and deionized water was used to prepare
solutions. All solutions were purified by filtration through a
0.45 mm filter. AMBnTßCD was custom synthesized at CycloLab
(Budapest, Hungary) with the details of the synthesis given earlier
(compound 14b, ref [43]). For planar lipid membrane measure-
ments, Low Binding Polymer Technology products were used for
cyclodextrin storage, dilution, and sampling (Sorenson BioScience,
Inc., Salt Lake City, UT). Methyl-ß-cyclodextrin was acquired
from Sigma-Aldrich (Munich, Germany). CompleteH protease
inhibitor was purchased from Roche (Mannheim, Germany).
Ponceau S was from AppliChem (Weiterstadt, Germany). The
protein molecular weight marker Page Ruler prestained Protein
ladderH was from Fermentas (St. Leon-Rot, Germany). Biotiny-
lated NAD+ was supplied by R&D Systems GmbH (Wiesbaden-
Nordenstadt, Germany). Baf A1 was obtained from Calbiochem
(Bad Soden, Germany). The enhanced chemiluminescence (ECL)
system was from Millipore (Schwalbach, Germany).
Cell culture and intoxication assays
Vero (African green monkey kidney) cells and CHO-K1
(Chinese hamster ovary) cells were from DSMZ (Braunschweig,
Germany). Vero cells were cultivated in MEM containing 10%
heat-inactivated fetal calf serum, 1.5 g/L sodium bicarbonate,
1 mM sodium-pyruvate, 2 mM L glutamine and 0.1 mM non-
essential amino acids. CHO-K1 cells were cultivated in DMEM
and HAM’s F12 containing 5% heat-inactivated fetal calf serum,
1 mM sodium-pyruvate and Penicillin-Streptomycin (1:100). The
cell lines were cultivated at 37uC and 5% CO2. Cells were
trypsinized and reseeded 15–20 times at most. For cytotoxicity
Figure 8. AMBnTßCD blocks the transmembrane pores formed
by C2IIa and Ib in planar lipid membranes at the multichannel
level. A. Multichannel C2II (top) and Ib (bottom)-induced conductance
changed by AMBnTßCD addition. The current recordings were
additionally filtered over 500-ms time interval. 0.1 M KCl solutions at
pH 6 were buffered by MES. Recordings were taken at 20 mV applied
voltage. B. Typical multichannel titration curves for C2IIa (left) and Ib
(right)-modified membranes show about 15 times lower IC50 values for
C2II channels. All multichannel measurements were taken at 20 mV
applied voltage.
doi:10.1371/journal.pone.0023927.g008
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experiments, cells were seeded in culture dishes and incubated in
serum-free medium with the respective toxin. The cells were
incubated with C2 toxin or iota toxin in the absence or presence of
the inhibitor AMBnTßCD in complete medium at 37uC, as
indicated in detail in the individual legends for the experiments.
After the given incubation periods, the cells were visualized by
using a Zeiss Axiovert 40CFl microscope (Oberkochen, Germany)
with a Jenoptik progress C10 CCD camera (Jena, Germany). The
cytopathic effects caused by the toxins were analysed in terms of
morphological changes, i.e. cell rounding.
Toxin translocation assay with intact cells
The pH-dependent translocation of C2I through C2IIa pores
across endosomal membranes was experimentally mimicked on
the surface of intact cultured cells as described in detail earlier
[24]. In brief, Vero cells were incubated with C2IIa/C2I at 4uC to
enable the binding of the toxin to the cell surface but to prevent
toxin internalization. Then, the cells were exposed to a short acidic
pulse (medium with pH 4.0) at 37uC to trigger the pore formation
of C2IIa into cell membranes and the translocation of C2I through
the pores across the cytoplasmic membrane into the cytosol. It is
important to note that bafilomycin A1 was present in the medium
during all of the steps to prevent the physiological uptake of the
toxin via acidified endosomal vesicles. The toxin-induced cell
rounding was monitored and documented to demonstrate that C2I
was indeed in the cytosol. The pH-dependent translocation of Iota
toxin across the cytoplasmic membranes of Vero cells was
performed mainly as described earlier [40].
Sequential ADP-ribosylation of actin in lysates from
toxin-treated cells
For ADP-ribosylation of actin in a cell-free system, 30 mg of
whole Vero lysate protein were incubated for 60 min at 37uC in a
buffer containing 20 mM Tris-HCl (pH 7.5), 1 mM EDTA,
1 mM DTT, 5 mM MgCl2, completeH protease inhibitor,
together with biotin-labelled NAD+ (10 mM) and 10 or 50 ng of
C2I protein. The reaction was stopped with 56SDS-sample buffer
(625 mM Tris/HCl pH 6.8, 20% SDS, 8.5% glycerol, 0.2%
bromphenol blue, 100 mM DTT) and the heating of the samples
for 5 min at 95uC. The samples were subjected to SDS-PAGE,
transferred to a nitrocellulose membrane and the biotin-labelled
ADP-ribosylated actin was detected with peroxidase-coupled
streptavidin and a subsequent chemiluminescence reaction.
Intensity of the biotin-labelled actin was determined by densitom-
etry using the Adobe Photoshop 7.0 software.
ADP-ribosylation of actin by C2I in a cell-free system
Vero lysate (30 mg of protein) was incubated for 10 min at 37uC
in a volume of 25 ml with 50 ng of C2I and 10 mM biotin-labelled
NAD+ in the presence or absence of AMBnTßCD (20 mM final
concentration). Samples were subjected to SDS-PAGE and blotted
onto a nitrocellulose membrane. ADP-ribosylated, i.e. biotin-
labelled, actin was detected with streptavidin-peroxidase and the
ECL system. The intensity of the biotin-labelled actin was
determined by densitometry using the Adobe Photoshop 7.0
software.
Figure 9. AMBnTßCD blocks the single pores formed by C2IIa
and Ib in planar lipid membranes. A. Currents through single C2IIa
(left) and Ib (right) channels at 50 mV applied voltage. The two topmost
tracks represent the AMBnTßCD-free control experiments. The fast
flickering between open and closed states (1/f noise) was mostly but
not completely removed here by averaging over 100-ms time interval.
In the presence of increasing AMBnTßCD, the channels were
spontaneously blocked (three lower current tracks). The dashed lines
represent zero current levels. B. Typical time histograms of AMBnTßCD-
induced C2IIa (top) and Ib (bottom) current fluctuations. Original
current recordings collected with 15 kHz filter and 50 kHz sampling
were additionally filtered with a 300 Hz filter to exclude most of the
high-frequency 1/f events. Toff represents the time channels spent in
the blocked state and Ton is the time between successful blockages.
Data were fitted by direct single-exponential (i.e. log probability) fitting
[79]. The fits were obtained using variable metrics as a search method
and maximum likelihood as a minimization method. Measurements
were performed in 1 M KCl solutions at pH 6 and 50 mV applied
voltage. 0.4 mM and 2.3 mM AMBnTßCD concentrations were used for
the C2IIa and Ib time-histograms, respectively, as statistically more
represented.
doi:10.1371/journal.pone.0023927.g009
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SDS-PAGE and immunoblot analysis
For immunoblot analysis of cell-associated C2I, equal amounts
of cell lysate protein were subjected to SDS-PAGE according to
the Laemmli method [76]. Subsequently, the proteins were
transferred to a nitrocellulose membrane (Whatman, Dassel,
Germany) what was confirmed by staining of the blotted proteins
with Ponceau S. The membrane was blocked for 30 min at room
temperature with 5% non-fat dry milk in PBS containing 0.1%
Tween-20 (PBS-T). To detect C2I, the membrane was probed
with a specific antibody raised against the N-terminal domain of
C2I (produced in rabbits by Pineda, Berlin, Germany). After
washing with PBS-T, the membrane was incubated with an anti-
rabbit antibody coupled to horseradish peroxidase (Santa-Cruz,
Heidelberg, Germany), and then washed again. C2I was visualized
using the ECL system according to the manufacturer’s instruc-
tions.
Channel Reconstitution into Planar Lipid Bilayers
To form solvent-free planar lipid bilayers with the lipid
monolayer opposition technique [77], we used a 5 mg/mL stock
solution of diphytanoyl phosphatidylcholine in pentane. Bilayer
lipid membranes were formed on a 60-mm (for single-channel
measurements) or 150-mm (for multichannel measurements)
diameter aperture in the 15-mm-thick Teflon film that separated
the two compartments as described in detail before [78]. The
0.1 M and 1 M aqueous solutions of KCl were buffered at pH 6
(MES) at room temperature (2360.5)uC. We also performed
several control measurements in MES-free solutions at pH 6.
Single channels were formed by adding (0.2–0.5) ml of 48 ng ml21
solution of C2IIa or (0.2–1) ml of 2.5 mg ml21 solution of Ib to the
1.5 ml aqueous phase on the cis half of the chamber. For
multichannel experiments, we applied about 1–2 ml of 48 mg ml21
C2IIa or 2–3 ml of 2.5 mg ml21 Ib stock solutions to the cis-side of
the membrane. Under this protocol, C2IIa and Ib channel
insertions were always directional as judged by channel conduc-
tance asymmetry in the applied transmembrane voltage. The
electrical potential difference across the lipid bilayer was applied
with a pair of Ag-AgCl electrodes in 2 M KCl, 1.5% agarose
bridges. Multichannel measurements were performed at 20 mV
and single-channel measurements at 50 mV. The applied
potential is defined as positive if it is higher on the side of protein
addition (cis-side).
Conductance measurements were done using an Axopatch
200B amplifier (Axon Instruments, Inc., Foster City, CA) in the
voltage clamp mode. Signals were filtered by a low-pass 8-pole
Butterworth filter (Model 9002, Frequency Devices, Inc., Haver-
hill, MA) at 15 Hz for multichannel and 15 kHz for single-channel
systems and sampled with a frequency of 50 Hz and 50 kHz in the
multi- and single-channel experiments, respectively. Amplitude,
lifetime, and fluctuation analysis was performed with ClampFit
10.2 (Molecular Devices) and OriginPro 8.5 (OriginLab) software
as well as with software developed in house.
Reproducibility of the experiments and statistics
All experiments were performed independently at least two
times. The results from the representative experiments are shown
in the figures. Values (n = 3) are calculated as mean 6 standard
deviation (S.D.) using the Prism4 Software (GraphPad Software,
Inc., La Jolla, CA, USA). The values shown are the average of 3
trials and the error bars represent standard error of the mean.
Significance was tested by using the student’s t-test (***p,0.0005;
** p,0.005; *p,0.05; n.s. = not significant).
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28. Stiles BG, Blöcker D, Hale ML, Guetthoff MA, Barth H (2002) Clostridium
botulinum C2 toxin: binding studies with fluorescence-activated cytometry.
Toxicon 40: 1135–1140.
29. Schleberger C, Hochmann H, Barth H, Aktories K, Schulz GE (2006) Structure and
action of the binary C2 toxin from Clostridium botulinum. J Mol Biol 364: 705–715.
30. Kaiser E, Haug G, Hliscs M, Aktories K, Barth H (2006) Formation of a
biologically active toxin complex of the binary Clostridium botulinum C2 toxin
without cell membrane interaction. Biochemistry 45: 13361–13368.
31. Nagahama M, Hagiyama T, Kojima T, Aoyanagi K, Takahashi C, et al. (2009)
Binding and internalization of Clostridium botulinum C2 toxin. J Infect Immun 77:
5139–5148.
32. Pust S, Barth H, Sandvig K (2010) Clostridium botulinum C2 toxin is internalized
by clathrin- and Rho-dependent mechanisms. Cell Microbiol 12: 1809–1820.
33. Haug G, Wilde C, Leemhuis J, Meyer DK, Aktories K, et al. (2003) Cellular
uptake of Clostridium botulinum C2 toxin: membrane translocation of a fusion toxin
requires unfolding of its dihydrofolate reductase domain. Biochemistry 42:
15284–15291.
34. Haug G, Leemhuis J, Tiemann D, Meyer DK, Aktories K, et al. (2003) The host
cell chaperone Hsp90 is essential for translocation of the binary Clostridium
botulinum C2 toxin into the cytosol. J Biol Chem 278: 32266–32274.
35. Kaiser E, Pust S, Kroll C, Barth H (2009) Cyclophilin A facilitates translocation
of the Clostridium botulinum C2 toxin across membranes of acidified endosomes
into the cytosol of mammalian cells. Cell Microbiol 11: 780–795.
36. Schmid A, Benz R, Just I, Aktories K (1994) Interaction of Clostridium botulinum C2
toxin with lipid bilayer membranes. Formation of cation-selective channels and
inhibition of channel function by chloroquine. J Biol Chem 269: 16706–16711.
37. Bachmeyer C, Benz R, Barth H, Aktories K, Gilbert M, et al. (2001) Interaction
of C2 toxin with lipid bilayer membranes and Vero cells: inhibition of channel
function by chloroquine and related compounds in vitro and intoxification in
vivo. FASEB J 15: 1658–1660.
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